Creped prebiotic tissue

Patent metadata

Field	Value
Publication number	US-9744248-B2
Application number	US-201615367331-A
Country	US
Kind code	B2
Filing date	Dec 2, 2016
Priority date	Sep 30, 2014
Publication date	Aug 29, 2017
Grant date	Aug 29, 2017

Abstract

The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy bacteria such as Bifidobacterium spp. or Lactobacillus spp. without promoting growth of enteropathogenic bacteria. The tissue products provide these benefits yet have a GMT greater than about 500, a Stiffness Index less than about 20 and a TS7 value less than about 10.

First claim

What is claimed is:

1. A tissue product comprising at least one creped tissue web having a basis weight greater than 10 grams per square meter (gsm) and a bulk greater than 3 cubic centimeters per gram (cc/g) and comprising at least 2 mg/m 2 prebiotic selected from the group consisting of inulin, fructo-oligosaccharide (FOS), lactulose and galacto-oligosaccharide (GOS) and an α-hydroxy acid.

2. The tissue product of claim 1 having a TS7 value less than 10.

3. The tissue product of claim 1 having a basis weight from 30 to 45 gsm and a geometric mean tensile (GMT) strength greater than 500 g/3″.

4. The tissue product of claim 1 wherein the α-hydroxy acid is selected from the group consisting of citric acid, lactic acid, methyllactic acid, phenyllactic acid, malic acid, mandelic acid, glycolic acid, tartronic acid, tartaric acid and gluconic acid.

5. The tissue product of claim 1 wherein the prebiotic is insulin and the α-hydroxy acid is citric acid or lactic acid.

6. The tissue product of claim 1 wherein the tissue web comprises from 2 to 1,000 mg/m 2 prebiotic.

7. The tissue product of claim 1 wherein the weight ratio of α-hydroxy acid to prebiotic agent is from 1:1 to 1:1,000.

8. The tissue product of claim 1 having a GM Slope from 10 to 20 kgf and a stiffness index less than 18.

9. The tissue product of claim 1 having a basis weight from 30 to 45 gsm, a bulk from 3 to 8 cc/g, a GMT from 700 to a 1,000 g/3″ and a TS7 value from 8.0 to 10.

10. A method of manufacturing a prebiotic creped tissue web comprising the steps of dispersing cellulosic fibers to form a fiber slurry, forming a wet tissue web, partially dewatering the wet tissue web, applying a creping composition comprising prebiotic selected from the group consisting of insulin, fructo-oligosaccharide (FOS), lactulose and galacto-oligosaccharide (GOS) and an α-hydroxy acid to a creping cylinder, pressing the partially dewatered tissue web to the creping cylinder, drying the tissue web and creping the dried tissue web from the creping cylinder.

11. The method of claim 10 wherein the creping composition further comprises an adhesive agent selected from the group consisting of polyvinyl alcohol, ethylene/vinyl acetate copolymer, animal glue, polyamidoamine-epichlorohydrin resins (PAE resins) and polyvinyl acetate and optionally a release agent selected from the group consisting of aliphatic polyols or oligomers thereof having a number average molecular weight of less than 600, polyalkanolamines, aromatic sulfonamides and pyrrolidone.

12. The method of claim 10 wherein the creping composition further comprises water and the composition comprises from 1 to 100 mg/L prebiotic.

13. The method of claim 10 wherein the creping composition is applied to the creping cylinder at an add-on level from 10 to 2,000 mg per square meter of creping cylinder surface area (mg/m 2 ).

14. The method of claim 10 wherein the creping composition is applied to the creping cylinder at an add-on level greater than 1,000 mg/m 2 .

15. The method of claim 10 wherein the α-hydroxy acid selected from the group consisting of citric acid, lactic acid, methyllactic acid, phenyllactic acid, malic acid, mandelic acid, glycolic acid, tartronic acid, tartaric acid and gluconic acid.

16. The method of claim 10 wherein the weight ratio of α-hydroxy acid to prebiotic agent is from 1:100 to 1:500.

17. The method of claim 10 wherein the prebiotic is insulin or fructo-oligosaccharide (FOS) and the α-hydroxy acid is citric acid or lactic acid.

18. The method of claim 10 wherein the web has a basis weight from 10 to 30 gsm, a geometric mean tensile (GMT) strength greater than 500 g/3″ and a TS7 less than 10.

Assignees

• Kimberly Clark Co

Inventors

• Zawadzki Michael Andrew
• Johnson Jeffrey Janne
• Koenig David William
• Vanden Heuvel Amy Lynn
• Moline David Andrew
• Vongsa Rebecca Ann
• Uttecht Cathleen Mae
• Waldroup Donald Eugene

Classifications

• A61K31/733 Primary

  Fructosans, e.g. inulin · CPC title

• A61F2/04

  Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95) · CPC title

• D21H27/00

  Special paper not otherwise provided for, e.g. made by multi-step processes · CPC title

• B31F1/126

  including making of the paper to be crêped · CPC title

• B31F1/12

  Crêping · CPC title